|
| 36214668 | Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung Cancer. | Mol Cancer Res | 2023 |
| 36535627 | Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model. | J Thorac Oncol | 2023 |
| 34648945 | Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase Inhibitors. | J Thorac Oncol | 2022 |
| 35383171 | Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes. | Nat Commun | 2022 |
| 36551709 | CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling. | Cancers (Basel) | 2022 |
| 36439025 | Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts. | Cancer Inform | 2022 |
| 34284202 | Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts. | Transl Oncol | 2021 |
| 34788078 | Assessing therapy response in patient-derived xenografts. | Sci Transl Med | 2021 |
| 34011980 | Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. | Sci Rep | 2021 |
| 32521388 | BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer. | Lung Cancer | 2020 |
| 31694835 | Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. | Clin Cancer Res | 2020 |
| 32094923 | A drug discovery platform to identify compounds that inhibit EGFR triple mutants. | Nat Chem Biol | 2020 |
| 32903271 | Cancer proteome and metabolite changes linked to SHMT2. | PLoS One | 2020 |
| 33023139 | Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma. | Pharmaceuticals (Basel) | 2020 |
| 32447118 | EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models. | Lung Cancer | 2020 |
| 30670085 | Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15. | J Immunother Cancer | 2019 |
| 31330989 | Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer. | Cancers (Basel) | 2019 |
| 31383733 | CD45<sup>+</sup>CD326<sup>+</sup> Cells are Predictive of Poor Prognosis in Non-Small Cell Lung Cancer Patients. | Clin Cancer Res | 2019 |
| 29145543 | Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. | JAMA Oncol | 2018 |
| 30093452 | Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <i>PIK3CA</i>-Mutant Lung Squamous Cell Carcinoma. | Clin Cancer Res | 2018 |
| 30108107 | A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium. | Clin Cancer Res | 2018 |
| 27750381 | Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors. | Int J Cancer | 2017 |
| 29156674 | Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts. | Oncotarget | 2017 |
| 26148229 | Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer. | Oncogene | 2016 |
| 27880766 | SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis. | PLoS Biol | 2016 |
| 27613526 | An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib. | J Thorac Oncol | 2016 |
| 26926157 | Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model. | Clin Lung Cancer | 2016 |
| 25784717 | CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. | Mol Cancer Res | 2015 |
| 26124487 | Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. | J Clin Oncol | 2015 |
| 26095073 | Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. | Lung Cancer | 2015 |
| 24453208 | Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. | Proteomics | 2014 |
| 25429762 | Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact. | Nat Commun | 2014 |
| 20815376 | Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. | J Proteome Res | 2011 |
| 21352589 | The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. | Head Neck Oncol | 2011 |
| 21081655 | The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer. | Clin Cancer Res | 2011 |
| 20042973 | A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer. | Am J Clin Oncol | 2010 |
| 20113529 | Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. | Mol Cancer | 2010 |
| 20197396 | Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort. | Mol Cancer Ther | 2010 |
| 18924149 | Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models. | Int J Cancer | 2009 |
| 17579866 | Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo. | Cancer Chemother Pharmacol | 2008 |
| 18254976 | Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis. | BMC Cancer | 2008 |
| 17326824 | Quantitative image analysis of immunohistochemical stains using a CMYK color model. | Diagn Pathol | 2007 |
| 17895832 | Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. | Pancreas | 2007 |
| 17409959 | Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. | J Thorac Oncol | 2006 |
| 16435192 | A comparative study of cytoplasmic granules imaged by the real-time microscope, Nile Red and Filipin in fibroblasts from patients with lipid storage diseases. | J Inherit Metab Dis | 2005 |
| 15486191 | The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. | Mol Cancer Ther | 2004 |
| 15306050 | Altered mitochondrial structure and motion dynamics in living cells with energy metabolism defects revealed by real time microscope imaging. | Microsc Microanal | 2004 |
| 12879457 | Oxidative stress is generated via the mitochondrial respiratory chain during plant cell apoptosis. | Cytometry A | 2003 |
| 11464217 | The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2. | Cell Death Differ | 2001 |
| 11262191 | Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents. | Exp Cell Res | 2001 |